{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T15:55:41Z","timestamp":1662047741007},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,6,3]],"date-time":"2016-06-03T00:00:00Z","timestamp":1464912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,6,3]],"date-time":"2016-06-03T00:00:00Z","timestamp":1464912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1038\/leu.2016.109","type":"journal-article","created":{"date-parts":[[2016,6,3]],"date-time":"2016-06-03T09:02:58Z","timestamp":1464944578000},"page":"1800-1801","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Response to \u2018PET after response to R-CHOP in primary mediastinal large B-cell lymphoma\u2019"],"prefix":"10.1038","volume":"30","author":[{"given":"TP","family":"Vassilakopoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Papageorgiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GA","family":"Pangalis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Chatziioannou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MK","family":"Angelopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Panayiotidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Konstantopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Rondogianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,3]]},"reference":[{"key":"BFleu2016109_CR1","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1038\/leu.2016.103","volume":"30","author":"K Lontos","year":"2016","unstructured":"Lontos K . PET\/CT in patients with primary mediastinal large B-cell lymphoma responding to rituximab-CHOP. Leukemia 2016; 30: 1799\u20131800.","journal-title":"Leukemia"},{"key":"BFleu2016109_CR2","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/leu.2015.120","volume":"30","author":"TP Vassilakopoulos","year":"2016","unstructured":"Vassilakopoulos TP, Pangalis GA, Chatziioannou S, Papageorgiou S, Angelopoulou MK, Galani Z et al. PET\/CT in patients with primary mediastinal large B-cell lymphoma responding to Rituximab-CHOP: an analysis of 106 patients regarding prognostic significance and implications for subsequent radiotherapy. Leukemia 2016; 30: 238\u2013242.","journal-title":"Leukemia"},{"key":"BFleu2016109_CR3","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1093\/annonc\/mdq418","volume":"22","author":"M Rieger","year":"2011","unstructured":"Rieger M, Osterborg A, Pettengell R, White D, Gill D, Walewski J et al. Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study. Ann Oncol 2011; 22: 664\u2013670.","journal-title":"Ann Oncol"},{"key":"BFleu2016109_CR4","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3109\/10428194.2013.810738","volume":"55","author":"JD Soumerai","year":"2014","unstructured":"Soumerai JD, Hellmann MD, Feng Y, Sohani AR, Toomey CE, Barnes JA et al. Treatment of primary mediastinal B-cell lymphoma with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone is associated with a high rate of primary refractory disease. Leuk Lymphoma 2014; 55: 538\u2013543.","journal-title":"Leuk Lymphoma"},{"key":"BFleu2016109_CR5","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1007\/s12185-010-0536-6","volume":"91","author":"HK Ahn","year":"2010","unstructured":"Ahn HK, Kim SJ, Yun J, Yi JH, Kim JH, Won JH et al. Improved treatment outcome of primary mediastinal large B-cell lymphoma after introduction of rituximab in Korean patients. Int J Hematol 2010; 91: 456\u2013463.","journal-title":"Int J Hematol"},{"key":"BFleu2016109_CR6","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3109\/10428194.2010.550073","volume":"52","author":"WM Tai","year":"2011","unstructured":"Tai WM, Quah D, Yap SP, Tan SH, Tang T, Tay KW et al. Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factors in 41 consecutive Asian patients. Leuk Lymphoma 2011; 52: 604\u2013612.","journal-title":"Leuk Lymphoma"},{"key":"BFleu2016109_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1634\/theoncologist.2011-0275","volume":"17","author":"TP Vassilakopoulos","year":"2012","unstructured":"Vassilakopoulos TP, Pangalis GA, Katsigiannis A, Papageorgiou SG, Constantinou N, Terpos E et al. Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of care. Oncologist 2012; 17: 239\u2013249.","journal-title":"Oncologist"},{"key":"BFleu2016109_CR8","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1200\/JCO.2013.51.7524","volume":"32","author":"M Martelli","year":"2014","unstructured":"Martelli M, Ceriani L, Zucca E, Zinzani PL, Ferreri AJ, Vitolo U et al. [18F] fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 study. J Clin Oncol 2014; 32: 1769\u20131775.","journal-title":"J Clin Oncol"},{"key":"BFleu2016109_CR9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ijrobp.2015.02.006","volume":"92","author":"CC Pinnix","year":"2015","unstructured":"Pinnix CC, Dabaja B, Ahmed MA, Chuang HH, Castelloe C, Wogan CF et al. Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography. Int J Radiat Oncol Biol Phys 2015; 92: 113\u2013121.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFleu2016109_CR10","first-page":"S0360","volume":"pii","author":"AR Filippi","year":"2016","unstructured":"Filippi AR, Piva C, Levis M, Chiapella A, Caracciolo D, Bello M et al. Prognostic role of pre-radiotherapy FDG-PET for primary mediastinal B-cell lymphomas treated with R-CHOP or R-CHOP-like chemotherapy plus radiation. Int J Radiat Oncol Biol Phys 2016; pii: S0360\u20133016.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFleu2016109_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3109\/10428194.2014.929674","volume":"56","author":"TP Vassilakopoulos","year":"2015","unstructured":"Vassilakopoulos TP, Pangalis GA, Polliack A . A \u201cPET\u201d topic in primary mediastinal large B-cell lymphoma: positive or negative, and how to handle it in the end. Leuk Lymphoma 2015; 56: 3\u20135.","journal-title":"Leuk Lymphoma"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2016109.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2016109","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2016109.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:06:40Z","timestamp":1648742800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2016109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,3]]},"references-count":11,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["BFleu2016109"],"URL":"https:\/\/doi.org\/10.1038\/leu.2016.109","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,3]]},"assertion":[{"value":"3 June 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}